l Introduction
Liver diseases during pregnancy comprise an important area of common interest for both perinatologists and internists. On the basis of my own practical experiences and from an extensive review of the literature which by necessity includes the presentation of at times contrasting views of unsatisfactorily resolved Problems, I am attempting to give a review of the current knowledge. In liver disease äs in disease of other Organs during pregnancy there are essentially two questions: 1. How is the diseased organ, i.e. the liver influenced by pregnancy -will there be an improvement or deterioration of the disease? 2. What influence has the liver disease on the pregnancy, e.g. in reference to malformations, abortions, prematurity, and perinatal mortality?
Changes during normal pregnancy
Every pregnancy is a stress for the entire organism. While the cardiac Output increases by 40-50%, the minute volume through the liver rejnains at 1 1 / 2 liters/minute. Thus, the relative perfusion of the liver of normally 35% of the cardiac Output decreases during pregnancy to 20-25% [22, 27, 37, 77] . Pregnancy poses for the normal liver a functional stress whichistolerated withoutproblems by the normal liver. Histologicaliy there are no changes specific to pregnancy in light nor electron microscopy; there are only variances of nuclear size, an increased glycogen content and occasional fat deposition in a few liver cells, especially in the lobular centers [22, 27, 28, 60] . The metabolic stress on the liver from the pregnancy is expressed in some findings deviating from the norm. The Interpretation of these changes which are physiologic during pregnancy but abnormal at other times, poses difficulties for the clinician and makes the differential diagnosis of liver disease during pregnancy difficult. (Tab. I :eviews the biochemical changes during normal pregnancy. During the entire pregnancy the serum protein concentration is decreased. This is a genuine dysproteinemia rather than a dilution from the hydremia of pregnancy. Until delivery the protein contents falls continuously to levels under 6 g% [37] . Because the albumin decreases and the a-and 0-globulines increase, the albumin/globulin ratio decreases from 1.32 before pregnancy to 0.7 at the low point of protein changes on the 4th-6th postpartum day. The -globulins also slightly decreased. These changes of the serum protein composition lead to an increased Sedimentation rate from the second month of pregnancy on. Coagulation and fibrinolysis are changed typically during pregnancy. During pregnancy the physiological Inhibitors of fibrinolysis are increased, the total fibrinolytic activity is slightly reduced [65] . Most coagulation factors, especially fibrinogin, factors VII, VIII, IX, and X are increased. This results in an increased induction of soluble fibrin monomer complexes. The presence of these soluble fibrin monomer complexes in addition to the increase in activity concentration of some plasma coagulation factors is responsible for the slight hypercoagulability during normal pregnancy [53] . The number of platelets is unchanged during normal pregnancy and there are no physiological disturbances of platelet function [44] . The serum bilirubin level is usually in the normal ränge or maybe slightly increased because of the greater hemoglobin turnover. It has now been established that bilirubin can pass through the placenta [56] . Tab. II revie ws the serum enzymes during pregnancy [16] . Alkaline phosphatase (AP), a mixture of various isoenzymes from liver, bone, small bowel and placenta, markedly increases during pregnancy especially after the sixth month; it drops sharply 24 hours postpartum and is still slightly above normal on the sixth postpartum day [37] . The activity of alkaline phosphatase duringlate pregnancy is mostly due to the placenta-derivedheat-stable phosphatase portions [37, 41, 57] .
Curriculum vitae
Gamma-glutamyl-transpeptidase ( -GT), which occurs along the intra/and extrahepatic bile ducts and is localized in the mitochondria, is the most sensitive test for cholestasis [55] . This enzyme also is increased normally during pregnancy from the sixth pregnancy month on [16] .
Leucine-amino-peptidase (LAP) is more specific than the alkaline phosphatase and it is markediy elevated in cholestasis together with 7 -GT [15] . It is also increased during the last month of normal pregnancies [77] . The transaminases SGOT and SGPT are the most specific indicators for hepatocellular destruction [9, 37, 55] . Since the integrity of liver cells during pregnancy is generally not compromised SGOT and SGPT remain normal during uncomplicated pregnancies. The data from 304 normal pregnant women illustrated in Fig. 2 show a slight increase of these enzymes during the last threemonths of pregnancy [ 16] . During delivery and during the first few days postpartum a slight increase in SGOT and SGPT may be observed [27] . Enzymes indicating necrosis include lactate dehydrogenase (LDH), a relatively nonspecific enzyme, which occurs in addition to liver also in the cardiac and skeletal muscles [55] . From Tab. II a slight increase of LDH in the last two months of pregnancy may be noted [16] .
Of interest are enzyme examinations in newborns 24 hours after birth. As an expression of liver cell necrosis in the newborn after fetal heart rate decelerations during birth and after protracted deliveries with the assumption of hypoxic states, there is a significant increase of LDH, SGOT, SGPT and especially GLDH activity [54] .
Among the so-called liver function tests during pregnancy only the bromosulfophthalein test (BSP) has a certain validity. The BSP retention after 45 minutes should not exceed 8% in a normal pregnancy [22, 26, 42] , It is markedly increased in cholestasis [55] . In more than 60% of pregnancies the so-called cutaneous liver signs such äs palmar erythema or spider nevi occur [23] . They are not an expression of liver disease but rather due to the increased estrogen concentration and its vasodilatory effects. These cutaneous liver signs regress completely within 4-6 weeks after delivery.
Review of liver diseases during pregnancy
Little can be said äs to the prevalence of anicteric liver disease during pregnancy, since in the absence of jaundice äs lead Symptom an unknown number of liver diseases is not recognized [23] . It has been surmised that during pregnancy, too, anicteric illnesses are more common than icteric ones [45] . Obviously, icteric liver diseases during pregnancy are much better studies and described [23, 30, 37] .
Basically, any icteric illness may occur during pregnancy. These cases represent the random coexistence of pregnancy and liver disease. These, therefore, are referred to äs icterus in graviditate. In addition, there are liver diseases caused by the pregnancy itself. These have been designated äs icterus e graviditate, namely, icterus äs a consequence of pregnancy. Large case collections indicate a prevalence of icterus during pregnancy between .2 and 1.8 per/ 1000 [28, 30, 33, 45] . Thus, jaundice during pregnancy is a relatively rare Symptom. Of interest is a review by HAEMMERLI (Tab. III) about the incidence of varying forms of icterus, based on 456 cases [34] . A classification of icteric mothers during pregnancy is seen in Tab. IV. I will now describe separately the severe diseases summarized in Tab. IV. The interaction of liver disease in pregnancy will be emphasized and the question of a possibly necessary termination of pregnancy will be reviewed with each disease.
l Icterus in graviditate

Viral Hepatitis
Hepatitis is one of the most common infectious diseases with about 100,000 to 150,000 cases per This "non-A-non-B hepatitis" has become the most common form of post-transfusion hepatitis in the USA. The existence of at least two of these viruses has been discussed,however, there are no laboratöry tests for the identification at this time.
For clarification, the various nomenclatures used over the years are given in Tab. V with the older designations in parentheses.
The transmission of hepatitis A occürs primarily by the fecal-oral route. Transmission may also occur parenterally during the viremic stage. Transmission of hepatitis B virus occurs predominately parenterally, though recently it has been recognized that transmission is also possible by sputum or sexual 'contact. However, these alternate transmission pathways have no major impörtance. Quantitative analysis has shown that it takes 10-100 liter saliva or 1-10 tons of urine or sweat to accumulate the amounts of HSsAg contained in l ml serum [15] . Incubation time for hepatitis virus A is 2-6 weeks, for virus B 2-6 months. There is immunity against reinfection of the same type but no cross immunity. New studies have shown that infection with one antigen subtype confersno immunity against disease with another subtype. A description of the illness, laboratöry findings, immunological aspects, and therapy will not be given in this obstetrically oriented discussion [4, 6, . The susceptibüity for Hepatitis is -in contrast to older opinions -not different during pregnancy [37] . Hepatitis may'occur during all phases of pregnancy. In one review [75] Hepatitis was found in 13% during the first trimester, in 31% in the second, and in 56% in the third trimester.
If hepatitis begins during late-pregnancy, during or after birth several authors have seen a more severe course which converts into the chronic form, than in a comparison group in the same age [11, 22, 32] . However, other authors reported that there were no differences in duration, severity, and fatal outcome of the illness during pregnancy; some even have stated that the course is milder and shorter [l, 4, 33, 45] . The mortality of hepatitis during pregnancy in this geographic area is not different than the mortality from hepatitis of an unpregnant woman of the same age [l, 33, 45, 50] . Severe cases and high mortality have always been observed if additional risk factors were present [2, 11, 17] , Data from developing countries in Asia and Africa with poor nutritional conditions indicate a maternal mortality of 50-70%. The assumption might be justified that the protein malnutrition during the increased need for protein during pregnancy has an unfavorable influence on the course and outcome of the hepatitis [37] . Proven pathways of the infection with hepatitis on the infant are oral-fecal postpartum, hematogenous infection if the infant is injured during birth, the maternal-fetal microtransfusion in the presence of the placental lesion, and colostrum. A transplacental transmission of hepatitis virus or HB-Ag must be assumed [5, 11, 14, 48, 66] . If the maternal disease occurs during the first trimester the fetal case rate is very low [66] . Evidently during the clinical maternal illness the placental foci are attacked by maternal antibodies before infection of the fetus itself [72] . The risks for neonatal infection increases the closer the maternal hepatitis infection occurs to the delivery date [66, 67] . With illness during the third trimester until two months postpartum HB-Ag presence in the newborn in 70-80% can be shown [66] . Maternal jaundice regardless of the etiology has no special influence on the fetus because infants of icteric mothers are usually born without marked jaundice.
Because of itsprotein-bindingbilirubin presumably passes only poorly the placental barrier [52] . Data on the incidence of abortions vary between reports of no increase [39, 75] and 25% [72] in manifest maternal hepatitis during the first trimester. Similarly, figures on the incidence of stillbirths vary, with the highest being given äs 22.8% [69] . Generally, the rate of stillbirths following hepatitis in the first and second trimester does not differ from that in other pregnancies [36, 39, 75] while stillbirths after hepatitis in the third trimester defmitely are increased [75] . By contrast there is a definite increase of prematurity to 15-35%, especially with disease in the third trimester [36, 37, 39, 72, 75] . The incidence of prematurity is the same in infected fetuses or in HB-Ag negative newborns [66, 67] . It is unknown whether this marked increase of prematurity is due to the acute maternal disease or due to the direct effect of the virus on the fetus or placenta.
There is some indication that the premature onset of labor is due to another mechanism because jaundice during pregnancy regardless of its etiology pre-disposes for prematurity [37] . In addition to a disturbance of the metabolism of placental hormones the increase in bile acids and fatty acids might lead to an increased tone of the uterus muscle and thus trigger premature labor [45] . As a consequence of the increased incidence of prematurity, perinatal mortality is increased, primarily postpartum mortality. This is equally true for hepatitis äs for all other liver diseases associated with jaundice. The prevention of prematurity in diseases associated with icterus is an urgent obstetrical problem. Tocolytic drugs of the beta-mimetic type are not absolutely contraindicated in liver disease. However, if the estimated fetal weight is above 2000 grams one should not necessarily insist on tocolysis because, given the current progress in neonatal pediatrics, these children have a good to excellent extra-uterine survival chance, especially after fetal lung maturity has been stimulated. On the other hand RICHTER and WIEST [63] consider hepatitis äs a contra-indication for tocolysis because the metabolic action of beta-mimetic additional stress the heptic metabolism. Whether this is also valid for cholestatic icterus of pregnancy has not been defined. Because of the possibility for neonatal infection and the additional stress of the mothers, they should not nurse the infant [13, 37] . The incidence of intrauterine growth retardation and dysmaturity is not increased with hepatitis [36] .
There has been much discussion on the possible association between viral hepatitis and fetal malformations. According to TÖNDURY there can be no question about the occurance of embryonal disturbances from the hepatitis virus. However, a specific syndrome of hepatitis embryopathy has not been described [73] . A number of case reports can be found about malformations in infants whose mothers contracted viral hepatitis during early pregnancy. In a large number of these case reports the correlation appears doubtful [37] .
Assuming an incidence of malformation of 2-3% in the general population the malformation rate of 3.5% found in series of 528 cases is not significantly increased [20, 21] . Another series of 555 pregnant women with hepatitis yielded a malformation rate of only 2.6% [39] . Some authors have cited an association between viral hepatitis and mongolism äs indication for virus-induced chromsomal changes; however, this has not been proven beyond doubt to date [37, 48, 71, 77] .
A special Situation occurs if the conception occurs at the time of an acute viral hepatitis. During this phase of hepatitis, cell cultures of peripheral lymphocytes show a 7-fold increased rate of abnormalities with Australia antigen positive hepatitis and a 2-fold increase in patients with Australia antigen negative hepatitis [74] . No practical consequence can be derived from these fmdings nor from the fact that hematogenous transplacental dissemination of the virus is possible in all stages of pregnancy [72] .
It may be assumed äs certain that the course of hepatitis is not influenced by either continuation or termination of pregnancy [37] . Termination may not halt the deterioration of a case of hepatitis. Permanent liver damage such äs the transition irito a chronic form do not occur more frequently in pregnant than in non-pregnant patients.
Acute fulminant viral hepatitis, i.e., acute yellow liver atrophy has a very high'mortality of 50-80% even without pregnancy. Termination of pregnancy does not change this prognosis. It usually occurs too late and poses an additional risk [61] . Thus, these facts do not justify termination per se and viral hepatitis with maybe the exception of the extremely acute cases [75] . The prophylaxis of viral hepatitis has seen new aspects in the past few years: For hepatitis A it has been shown that a passive immünization with -gammaglobulin before and after exposure decreased the incidence of -hepatitis, mitigate the course and prevents death [15] The newly available special immune globulin with a high content of Anti-HB s (Anti-HB s Ig) [18, 58, 68] offers an effective prophylaxis against hepatitis B following exposure and this protection may include the neonatal period [47] . Initial experiences have been made with active immünization against hepatitis B [46] .
Chronic hepatitis. Cirrhosis.
Chronic hepatitis may be associated with viral disease, drugs, or of unknown etiology. An immune mechanism has been speculated for the chronic hepatitis of unclear etiology [7, 78] . Clinically cases are divided into chronic persistent hepatitis with a benign course and a chronic active and chronic aggressive hepatitis with often progressive course into cirrhosis. While the course of chronic persistent hepatitis during pregnancy is not different this is not necessarily true for chronic aggressive hepatitis, and it may vary noticably in individual cases [23] . Various authors have reported an increase in the incidence of chronic aggressive hepatitis with cirrhosis in relatively young age ranges [40, 51] . Thus, cases with cirrhosis during pregnancy may increase inthefuture [51] . To date it has been rather rare that a patient with cirrhosis conceived because the disease usually occurred after menopause. Even cirrhotic patients during the reproductive age rarely become pregnant because the disturbed estrogen metabolism leads to secondary infertility in anpvulatory cycles.
Indeed, pregnancy in a cirrhotic patient may indicate sufficient liver function [38] . While wome authors report a deterioration of the cirrhosis during pregnancy [22, 32] , others have not seen a difference on the long-term prognosis and even improvement of the liver function has been noted [38, 51, 59, 77] . The principal risk for the pregnant patient is hematemesis in the presence of portal hypertension and possible gastro-esophageal reflux esophagitis. The prognosis of mother and child is determined by the complications of liver cirrhosis (portal hypertension, ascites, hepatic coma) [39] . About 20% of pregnant patient with cirrhosis experience liver failure [37] . Because of the complications a close contact between obstetrician and hepatologist is necessary, especially with chronic aggressive hepatitis and even more well with liver cirrhosis in order to discuss the question of continuation or termination of the pregnancy. Each case must be analyzed individually.
Immunosuppressive therapy during pregnancy should be discontinued because of the possible effects on the fetus [51, 77] . Steroid treatment of chronic active hepatitis may be continued during pregnancy [51] . However, the assessment of estriol values for the surveillance of the fetal-placental unit is impaired with this medication. In chronic forms of hepatitis and with cirrhosis prematurity (up to 50%), stillbirths (up to 20%) and also neonatal mortality is increased äs aconsequenceof the high prematurity rate [38, 39, 40] . The rate of hypotrophic infants is also increased [39] . Perinatal mortality of mature infants, however, is not increased [37] . Surviving infants do not have liver damage [51] and the rate of malformations is not increased [37, 24] , but the rate of abortions is [38, 39] . Delivery under anesthesia which causes stress for the liver, e.g. halothane, should be avoided; regional anesthesias are the alternatives. Because of thelackofcoagulationfactors in cirrhotic conditions there may be considerable hemorrhages during the third stage [51] . Chronic aggressive hepatitis and compensated liver cirrhosis pose relative indications for termination of pregnancy while decompensated liver cirrhosis with ascites, esophageal varices, hemorrhages, and early coma, the termination is absolutely indicated.
It should be carried out with the least stressful method [61] . Because of the identical Symptoms primary bilious cirrhosis is often confused with the recurring intraheptic cholestasis of pregnancy [51] . In bilious cirrhosis the p'rematurity rate and thus perinatal mortality is increased äs well. However, the course of the disease is not influenced by pregnancy [61] .
Rare forms of icterus
l .3.1 Drug-induced jaundice
Numerous cases of jaundice, including those during pregnancy, can be explained by various drugs (antihistamines, antimetics, sedatives, tuberculostatics, halothane, etc.) [37] . Many of these substances are indirect hepatotoxic which cause liver changes in only a small percent of exposed individuals äs an idiosyncrasy. Their action is independent of the dose and occurs after varying duration of the administration. Evidently predisposing factors in the individuals play a role [10] . Morphologie changes in the liver vary greatly [62] . Cases of drug jaundice do not differ in their course or severity during pregnancy [83].
l .3.2 Extrahepatic cholestasis
Gall stones and subsequent extrahepatic obstructive jaundice does not occur during pregnancy any more frequently than in non-pregnant patients, nor are Symptoms and therapy different [37] . This is also true for inflammatory changes of the bile ducts.
l .3.3 Functional hyperbilirubinemia
In functional disturbances of the bilirubin metabolism with hyperbilirubinemia (Tab. VI [76] ; of obstetrical interest only groups Ic, 2a, 2b) the complaints increase during pregnancy. Often mild subclinical hyperbilirubinemia become clinically manifest during intercurrent illness, trauma, alcohol abuse, surgery, oral contraceptives, or pregnancy. There is no treatment for these congenital hyperbilirubinemias regardless of the presence or absence Type CLAYTON-JUBERG (BYLER'S disease) of pregnancy. There is usually no maternal indication for termination of pregnancy. Because of the increased jaundice the rate of prematurity may be slightly increased. Thusfar, about 30 cases of pregnancy in DUBIN JOHNSON syndrome have beendescribed [3, 19] . GILBERT'S disease, a relatively harmless metabolic anomaly with slight increase of unconjugated bilirubin up to maximally 5 mg%, is not influenced by pregnancy and nor does it have an effect upon the pregnancy.
l .3.4 Hemolytic jaundice
While jaundice usually indicates liver involvement, it may occur without impaired liver function. Thus, there is usually a mild jaundice in the congenital and acquired hemolytic anemias;primarily the unconjugated bilirubin is increased [37] . The association of pregnancy and hemolytic anemia in most cases is a serious complication and termination is indicated in many cases. It must be taken into account that many forms of hemolytic anemia deteriorate progressively during pregnancy and that severe hemolytic crises may occur [35] , especially in the third trimester and during birth. These correlations have been especially well studied in sickle cell anemia. Pregnancy with this disease is a severe stress with a high maternal [10] and infant mortality (50%) äs a consequence of the high prematurity rate [25] . During the deterioration caused by the pregnancy of these hemolytic anemias there is an increased tendency for thrombosis, leading to placental infarction and abruptio. Sickle Cell anemia is an indication for termination of pregnancy äs is hereditary spherocytosis and the thalassemias.
Qther forms of jaundice
Jaundice may occur in the course of complications of pregnancy associated with disseminated intravascular coagulation (endotoxin shock) or in septicemia with severe pyelonephritis. This has to be separated from jaundice with primary liver disease or bile duct disease [37] . Fortunately, the association between pregnancy and liver cell carcinoma is rare, but it is an absolute indication for termination of pregnancy since metastases into the fetus may occur [61 ] . Individual cases of pregnancy with liver tumors have been described [51] .
Icterus e graviditate
Intrahepatic cholestasis of pregnancy (idiopathic jaundice of pregnancy)
This syndrome has been described under many Synonyms in the literature [37] . In the pronounced form there is a visible jaundice and in the moderate variations there is generalized pruritus during pregnancy [37] . Next to viral hepatitis it is the second most common form of jaundice during pregnancy with about 20% [49] . The disease is observed in about 1:500 to 1:10,000 cases [22, 37, 49] . General health is only slightly impaired. The disease usually occurs after the 22nd week of gestation, rarely äs early äs the first trimester. Symptoms disappear shortly after delivery. These usually reoccur more severely during a subsequent pregnancy. The lead Symptom is the generalized pruritus, especially on the trank and extremities. The jaundice is rarely severe. Bilirubin levels rarely exceed 5-8 mg% and are predominately direct reacting (conjugated) bilirubin and they become normal during the postpartum days. Changes typical for cholestasis are seen in laboratory tests. Transaminases are slightly elevated, rarely above 300 units [42] , Histological examinations of liver biopsies in the light microscope demonstrate hepatic stasis with bile thrombi in the dilated bile canaliculi, especially around the central veins. There are no inflammatory reactions or indications of proliferation of mesenchymal cells [37] . The etiology of this disease is not completely understood [49, 51] . Probably it is a disturbance in the estrogen metabolism with a familiär disposition [37, 51] , which becomes manifest during pregnancy or with the use of estrogen· containing contraceptives. The illness is harmless for the pregnant patient. Reports on the prognosis for the child vary. A rate of prematurity of up to 40% explains the high perinatal mortality reported by some [29, 37, 49, 77] . There is no specific treatment and termination of pregnancy is not indicated [61] . The pruritus may be aleviated with the use of cholestyramine, a nonresorbable alkaline synthetic resin which binds bile salts in the intestine [49] , This Interrupts the enterohepatic circulation and the bile acids in the serum fall äs a consequence. It is clinically important to rule out viral hepatitis in the differential diagnosis.
Acute fatty liver of pregnancy
This is a fortunately rare, yet very severe, disease described first by STANDER and CRADDEN in 1934 [64] . The etiology is unknown. The disease usually begins very actuely in the 36 th to 40th week of gestation [37] . First signs, even before nausea and vomiting, are lethargy, depressive mood changes, and psychotic signs. In addition there are frequently neurological Symptoms. This psychotic phase which may precede the other Symptoms for up to 14 days is considered the typical initial sign of the disease [64] . This may be confused with the equally rare pregnancy psychoses. Later severe headache, intractable vomiting, -initially bilious, later coffee-ground -äs well äs abdominal pain. Among the severe problems are acute hemorrhages into the gastrointestinal tract, kidney, central nervous System, äs well äs the development of disseminated intravascular coagulopathy. Ultimately, oligouria or anuria occur äs well äs stupor and coma. The clinical course resembles that of the acute liver necrosis in viral hepatitis with the corresponding laboratory fmdings [37] , There are 118 cases reported in the literature [64] . Histologically characteristic is a picture of fatty changes at the central veins, with swollen, foamy and packed hepatocytes. The cytoplasm is displaced with numerous small vacuoles [37] . Therapy of fatty liver pregnancy is symptomatic. It includes [64] :
1. termination of pregnancy 2. treatment of hepatic coma 3.correction of imbalance in the metabolism of glucose, fluids, electrolytes and acid-base 4. treatment of coagulopathy These intensive measures have decreased the mortality of this disease during the last ten years from80%to45% [64] .
Toxemia of pregnancy
Some women with toxemia of pregnancy have jaundice during the course of hyperemesis gravidarum or eclampsia. These forms of jaundice constitute accompanying Symptoms of the underlying toxemia. A specific therapy of this firm of icterus is not possible nor is it necessary since the jaundice will disappear together with the underlying toxemia.
Liver disease and termination of pregnancy
Tab. 7 reviews indications for termination of pregnancy in relative and absolute terms according to literature data. Thus, there is an absolute indication with Questionable is termination with acute viral hepatitis, because the extent of the possible chromosome damage from the virus has not been well defined.
Discussion
The discussion of liver disease during pregnancy must emphasize the Separation of liver diseases caused by liver diseases specific to the pregnant state from those who occur also outside of pregnancy. Because of the problems with the differential diagnosis of infectious hepatitis from other diseases presenting with jaundice it is justified to isolate each patient with jaundice until an infectious process has been ruled out.
Since any icteric disease in pregnancy without regard to etiology and pathogenesis is also a considerable risk for the infant, the prenatal surveillance of the fetus must be intense. The question of the necessity for tocolysis with premature onset of labor because of the liver disease must be decided on an individual basis. Human placental lactogen äs an indicator of placental function is not influenced'by liver disease. The assay of estriol excretion in the urine or of serum estriol levels is not influenced äs long äs radio-immune assays are used in contrast to colorimetry [37] . Thus, an existing jaundice does not prevent the use of these parameters for monitoring the intrauterine fetal well-being.
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